Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.8900
+0.1220 (15.89%)
At close: Mar 28, 2025, 4:00 PM
1.050
+0.160 (17.94%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Conduit Pharmaceuticals Employees
Conduit Pharmaceuticals had 7 employees as of December 31, 2023.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,543,143
Market Cap
5.93M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CDT News
- 11 days ago - Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904 - GlobeNewsWire
- 24 days ago - Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel - GlobeNewsWire
- 5 weeks ago - Conduit Progresses Phase II of its AI Initiative with Sarborg - GlobeNewsWire
- 6 weeks ago - Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model - GlobeNewsWire
- 6 weeks ago - Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note - GlobeNewsWire
- 7 weeks ago - Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - GlobeNewsWire